COLUMBUS, Ohio – In only three short years, a local fundraising organization started by a single family has raised more than $300,000 for multiple myeloma research at The Ohio State University Comprehensive Cancer Center- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
, which stands for Multiple Myeloma Opportunities for Research and Education, was founded by Nancy Kaufmann and Steve Fink of Upper Arlington in 2008 to honor their daughter, Sarah Kaufmann-Fink, who was diagnosed with the rare and incurable blood cancer at the age of 22. Sarah, now 27, is in remission after a treatment regimen that included chemotherapy, radiation and a stem-cell transplant.
Fundraisers this year included the CelebrateMMORE gala in February and the MoveMMORE 5K race and 1-mile fun run in September.
Another fundraising group – Coaches Against Multiple Myeloma
– donated more than $27,000 to MMORE that they raised during a youth baseball tournament held in May at Berliner Park that attracted more than 120 teams from around the state. Multiple myeloma survivor and OSUCCC-James patient Matt Hare, 26, of New Albany, organized the baseball tournament with the help of his father, Doug Hare of Pataskala.
In addition, Matt Hare joined the 44-member RideMMORE Peloton that raised more than $50,000 in Pelotonia
, a grassroots bicycle tour held each August that raises money for cancer research at OSUCCC-James.
“As a result of these fundraising efforts, we are more quickly able to translate bench to bedside research, allowing us to start clinical trials with multiple myeloma patients much sooner,” said Dr. Don Benson, a hematologist and oncologists who specializes in researching and treating multiple myeloma at OSUCCC-James.
About 60,000 people in the United States have multiple myeloma, and more than 20,000 new cases are diagnosed annually. The average survival from diagnosis is less than 10 years.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute cancer.osu.edu
is one of only 40 Comprehensive Cancer Centers in the United States designated by the National Cancer Institute. Ranked by U.S. News & World Report among the top cancer hospitals in the nation, The James is the 180-bed adult patient-care component of the cancer program at The Ohio State University. The OSUCCC-James is one of only seven funded programs in the country approved by the NCI to conduct both Phase I and Phase II clinical trials.# # #
Medical Center Public Affairs and Media Relations